Stock Snapshot from
Vanda Pharmaceuticals IncAdd to My Watchlist
VNDA:USNASDAQ GMIndustry: Medical-Drugs
- 8.51Last
- 2.41 -22.07%Today's Change
- 10.92Previous Close
- 52 Week Low - High
Earnings
| EPS: Year Actual ttm | -0.850 |
| EPS: Year Est. 12/13 ttm | -0.990 |
| EPS: Quarterly Actual 3/13 | -0.15 |
| EPS: Quarterly Est. 6/13 | -0.22 |
| Price/Earnings ttm | -- |
| Relative Price/Earnings | -- |
| Earnings Growth Rate | -180.00 |
Company Description
| Vanda Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of clinical-stage, small molecule product candidates for central nervous system disorders. | |
| Revenue | $33 million |
| Net Income | $-28 million |
| Total Assets | $135 million |
| Employees | 40 |
| Web Site | www.vandapharmaceuticals.com |
Latest Headlines
No news available.
Watchlist
Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.